drugset / Trial / NCT05697614

The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children

NCT05697614

Phase 4 Unknown 100 enrolled Dr Cipto Mangunkusumo General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this interventional study is to learn about the efficacy and safety of first line anti epileptic drugs (AEDs) as substitution therapy for children who are resistant to second-line AEDs. The main question to answer it aims are : how much the difference proportion of responders (responders are children who achieve the decrease of seizure frequencies by 50%) how much time it is needed to achieve the decrease of seizure frequencies by 50% The patients who are eligible for the study and have given their consent, will be enrolled, divided into 2 groups, the control and intervention. The participant should follow the 14 weeks of intervention that consists of 6 phases : baseline, initial dose, titration dose, maintenance dose, tapering-off dose, and new combination maintenance dose.

Timeline

Start
2023-03-01
Primary completion
2023-05-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepin Unknown
Comparator Clobazam Small molecule
Comparator Lamotrigine Small molecule
Comparator Oxcarbazepine Small molecule
Subject Phenytoin Unknown
Subject Valproic Acid Small molecule

Indications